BJU Int 2021 Dec 13
The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.
Related Questions
Pretreatment PSA 25.3 with Gleason 4+3=7 and MRI suspicious for ECE. Eight months after pelvic nodal and prostate XRT to 79 Gy, PSA is 5.02 (down from...
New comment by Radiation Oncologist at Vanderbilt-Ingram Cancer Center ( July 21, 2023)
It's an excellent question, Dr. @Pollock. I do not think there is utility of repeating a PSMA PET in the post-treatment scenario as described.
While I personally wait for Pho...
With the advent of PSMA PET/CT, this is my study of choice for high risk prostate cancer. Are there scenarios where standard FDG PET is useful? For ex...
New comment by Radiation Oncologist at Lafayette Radiation Center ( August 25, 2024)
Late stage heavily treated when suspect NE differentiation. Ow no